The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: KALETRA     Injury: Lipodystrophy acquired     Quarter: 2016Q3

Total Records: 6     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
71171719 KALETRA Lipodystrophy acquired BRISTOL MYERS SQUIBB 52.00 YR M 0 20160922 US
118757793 KALETRA Lipodystrophy acquired GLAXOSMITHKLINE 26.70 YR M 0 20160929 JP
118761913 KALETRA Lipodystrophy acquired VIIV 26.70 YR M 0 20160929 JP
125422481 KALETRA Lipodystrophy acquired BRISTOL MYERS SQUIBB 48.00 YR M 0 20160708 JP
126434631 KALETRA Lipodystrophy acquired ROCHE 54.00 YR M 0 20160811 CA
730262226 KALETRA Lipodystrophy acquired MERCK 52.00 YR M 0 20160923 US

Total Records: 6     Number of Pages: 1